AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Traditional methods for diagnosing and monitoring Parkinson’s rely heavily on clinical observation and subjective assessments, which can often result in late diagnoses or inconsistent tracking of ...
Traditional methods for diagnosing and monitoring Parkinson’s rely heavily on clinical observation and subjective assessments, which can often result in late diagnoses or inconsistent tracking of ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Veterans diagnosed with post-traumatic stress disorder may experience thrashing sleep, which can lead to more extensive ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...
Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback